Executive Dysfunction Across Anxiety Severity Level: Evidence for Cognitive Plateau

焦虑严重程度各异的执行功能障碍:认知平台期的证据

阅读:1

Abstract

BACKGROUND: Anxiety disorders are increasingly recognized as involving neurocognitive impairments in executive functioning, including working memory, inhibitory control, and cognitive flexibility. However, Indian research has predominantly emphasized emotional and behavioural manifestations, leaving the neuropsychological correlates of anxiety severity underexplored. PURPOSE: To investigate the relationship and differences in executive functioning among individuals with varying levels of anxiety. METHOD: A cross-sectional study was conducted with 60 patients, classified into mild, moderate, or severe anxiety using the PROMIS Anxiety-Adult Short Form. Neuropsychological assessment included the Wechsler Memory Scale (WMI), Stroop Test (inhibitory control), and Wisconsin Card Sorting Test (conceptual processing). Data were analysed using ANOVA, post hoc comparisons, chi-square tests, Pearson's correlations, and linear regression. Ethical approval and informed consent were obtained. RESULTS: Significant group differences emerged across all domains (WMI: F = 6.87, p = .002; Stroop: F = 13.09, p < .001; WCST: F = 17.72, p < .001). Post hoc tests showed superior performance in the mild group relative to moderate and severe groups, with no significant differences between the latter two. Anxiety severity correlated negatively with executive functioning (r = -0.45 to -0.61, p < .01). Regression analyses confirmed severity as a significant predictor, explaining 20%-37% of variance in executive performance. CONCLUSION: Executive dysfunction worsens with increasing anxiety severity, with cognitive decline plateauing between moderate and severe levels. Strong correlations highlight severity as a critical determinant of working memory, inhibitory control, and conceptual processing. Findings underscore the need to integrate neuropsychological assessment and cognitive rehabilitation into anxiety management in Indian clinical settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。